Edition:
United Kingdom

‍Prosight Management reports a 6.9 percent passive stake in Eiger Biopharmaceuticals​


Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Eiger Biopharmaceuticals Inc :‍Prosight Management reports a 6.9 percent passive stake in Eiger Biopharmaceuticals​ as of Oct 31 - SEC filing.